We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
-4.04%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$78.1M
Cap. Flow
+$101M
Cap. Flow %
59.28%
Top 10 Hldgs %
98.47%
Holding
47
New
8
Increased
3
Reduced
2
Closed
26

Top Buys

Rank Stock Value
1
ACCD
Accolade Inc
ACCD
+$57.3M
2
BEAM icon
Beam Therapeutics
BEAM
+$21.3M
3
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
+$18.4M
4
VIR icon
Vir Biotechnology
VIR
+$5.09M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$4.85M

Top Sells

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$3.29M
2
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
+$3.23M
3
SOLY
Soliton, Inc.
SOLY
+$480K
4
PINS icon
Pinterest
PINS
+$187K
5
RP
RealPage, Inc.
RP
+$174K

Sector Composition

Rank Sector Weight
1 Healthcare 54.96%
2 Industrials 31.73%
3 Technology 3.55%
4 Communication Services 0.03%
5 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACCD
1
DELISTED
Accolade Inc
ACCD
$54M 31.71%
+1,191,326
New +$57.3M
TSHA icon
2
Taysha Gene Therapies
TSHA
$2.05B
$44.2M 25.95%
2,179,000
+179,000
+9% +$4.85M
BEAM icon
3
Beam Therapeutics
BEAM
$2.76B
$18M 10.54%
+224,390
New +$21.3M
VT icon
4
Vanguard Total World Stock ETF
VT
$81.4B
$16.5M 9.71%
170,025
– –
CDAK
5
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$12.8M 7.49%
+847,108
New +$18.4M
IMTX icon
6
Immatics
IMTX
$1.33B
$7.82M 4.59%
697,431
– –
TXN icon
7
Texas Instruments
TXN
$253B
$6.05M 3.55%
32,000
– –
VIR icon
8
Vir Biotechnology
VIR
$1.52B
$4.85M 2.84%
+94,513
New +$5.09M
SYRE icon
9
Spyre Therapeutics
SYRE
$9.18B
$2.21M 1.3%
11,187
– –
DNLI icon
10
Denali Therapeutics
DNLI
$4.04B
$1.35M 0.79%
+23,629
New +$1.58M
SOLY
11
DELISTED
Soliton, Inc.
SOLY
$1.32M 0.77%
75,000
-37,552
-33% -$480K
PLXP
12
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$566K 0.33%
62,673
– –
TFFP
13
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$299K 0.18%
883
-7,944
-90% -$3.23M
LXRX icon
14
Lexicon Pharmaceuticals
LXRX
$1.05B
$210K 0.12%
35,714
– –
APEN
15
DELISTED
Apollo Endosurgery, Inc.
APEN
$86K 0.05%
15,601
– –
META icon
16
Meta Platforms (Facebook)
META
$1.47T
$53K 0.03%
180
+160
+800% +$43.1K
UPS icon
17
United Parcel Service
UPS
$88.4B
$34K 0.02%
+200
New +$32.4K
TPL icon
18
Texas Pacific Land
TPL
$23.6B
$25K 0.01%
+144
New +$17.9K
AMZN icon
19
Amazon
AMZN
$2.88T
$9K 0.01%
60
+40
+200% +$6.34K
POR icon
20
Portland General Electric
POR
$5.74B
$6K ﹤0.01%
118
– –
PG icon
21
Procter & Gamble
PG
$335B
$3K ﹤0.01%
+20
New +$2.61K
AAPL icon
22
Apple
AAPL
$4.41T
– –
-88
Closed -$12K
BAX icon
23
Baxter International
BAX
$13.9B
– –
-125
Closed -$10K
BL icon
24
BlackLine
BL
$1.65B
– –
-75
Closed -$10K
DE icon
25
Deere & Co
DE
$167B
– –
-27
Closed -$7K
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q1 2021 Portfolio in Review

As of Q1 2021, University of Texas/Texas AM Investment Management Co (UTIMCO) held 47 positions worth $170M, up 85% from $92.3M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $101M of net new capital in Q1 2021, opening 8 new positions and adding to 3 existing holdings. Its largest new stake was Accolade Inc: 1,191,326 shares worth $54M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was TFF Pharmaceuticals, Inc. Common Stock, an estimated $3.23M trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q1 2021 buy was Accolade Inc: 1,191,326 shares worth $54M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Taysha Gene Therapies in Q1 2021, an estimated $4.85M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q1 2021 reduction was TFF Pharmaceuticals, Inc. Common Stock, cutting an estimated $3.23M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited BeOne Medicines Ltd in Q1 2021, selling an estimated $3.29M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 98% of its $170M portfolio in Q1 2021.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 8 new positions and closed 26 in Q1 2021.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 85% quarter-over-quarter to $170M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2021, filed 7 May 2021.